Study of proteomics in blood of women with breast cancer
Not Applicable
- Conditions
- Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
- Registration Number
- CTRI/2021/09/036703
- Lead Sponsor
- All India Institute of Medical Sciences New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Treatment naïve biopsy proven breast cancer women
Patients giving consent to participate in the study
Exclusion Criteria
pregnant and lactating women
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method study of Differential proteomics in treatment naïve breast cancer women <br/ ><br>Timepoint: Baseline <br/ ><br>
- Secondary Outcome Measures
Name Time Method Differential proteomics after Neo-adjuvant chemotherapy in patients receiving the sameTimepoint: 10-14 weeks from baseline